Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| AVANIR PHARMACEUTICALS | 108,797 | reported | 18 Dec 2014 | tx 78+1,231,862−798,015 |
| CARDIOGENESIS CORP /CA | 100,000 | reported | 21 Mar 2006 | tx 1+100,000 |
| Eledon Pharmaceuticals, Inc. | 52,500 | reported | 24 May 2017 | tx 2+62,510 |
| Urovant Sciences Ltd. | 0 | reported | 29 Mar 2021 | tx 9+150,929−286,031 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 29 Mar 2021 | OTHER | Urovant Sciences Ltd. | 68,971 | — | |
| 29 Mar 2021 | OTHER | Urovant Sciences Ltd. | 9,810 | — | |
| 29 Mar 2021 | OTHER | Urovant Sciences Ltd. | 70,000 | 0.00 USD | deriv |
| 29 Mar 2021 | OTHER | Urovant Sciences Ltd. | 133,500 | 0.00 USD | deriv |
| 29 Mar 2021 | OTHER | Urovant Sciences Ltd. | 3,750 | 0.00 USD | deriv |
| 01 May 2020 | GRANT_AWARD | Urovant Sciences Ltd. | 44,346 | 0.00 USD | |
| 07 Jan 2020 | GRANT_AWARD | Urovant Sciences Ltd. | 32,833 | 0.00 USD | |
| 06 Jan 2019 | GRANT_AWARD | Urovant Sciences Ltd. | 70,000 | 0.00 USD | deriv |
| 15 Oct 2018 | GRANT_AWARD | Urovant Sciences Ltd. | 3,750 | 0.00 USD | deriv |
| 24 May 2017 | GRANT_AWARD | Eledon Pharmaceuticals, Inc. | 52,500 | 0.00 USD | deriv |
| 10 May 2017 | PURCHASE | Eledon Pharmaceuticals, Inc. | 10,010 | 9.99 USD | first after silence |
| 18 Dec 2014 | SALE | AVANIR PHARMACEUTICALS | 5,780 | 16.93 USD | |
| 16 Dec 2014 | SALE | AVANIR PHARMACEUTICALS | 17,500 | 16.94 USD | |
| 16 Dec 2014 | SALE | AVANIR PHARMACEUTICALS | 12,500 | 16.94 USD | |
| 16 Dec 2014 | EXERCISE | AVANIR PHARMACEUTICALS | 17,500 | 4.18 USD | |
| 16 Dec 2014 | EXERCISE | AVANIR PHARMACEUTICALS | 12,500 | 2.59 USD | |
| 16 Dec 2014 | EXERCISE | AVANIR PHARMACEUTICALS | 12,500 | 0.00 USD | deriv |
| 16 Dec 2014 | EXERCISE | AVANIR PHARMACEUTICALS | 17,500 | 0.00 USD | deriv |
| 10 Nov 2014 | GRANT_AWARD | AVANIR PHARMACEUTICALS | 31,992 | — | |
| 10 Nov 2014 | GRANT_AWARD | AVANIR PHARMACEUTICALS | 19,844 | — | |
| 24 Oct 2014 | SALE | AVANIR PHARMACEUTICALS | 2,080 | 11.81 USD | |
| 15 Sept 2014 | SALE | AVANIR PHARMACEUTICALS | 55,000 | 9.45 USD | |
| 15 Sept 2014 | EXERCISE | AVANIR PHARMACEUTICALS | 55,000 | 0.00 USD | deriv |
| 26 Aug 2014 | SALE | AVANIR PHARMACEUTICALS | 2,110 | 6.10 USD | |
| 16 May 2014 | SALE | AVANIR PHARMACEUTICALS | 11,900 | 4.88 USD |
2 purchases reported after at least 12 months of silence — most recent on 10 May 2017.